Clinical Trial: Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: A Randomised, Double-blind, Double-dummy, Multi-centre, Comparative Parallel-group Study to Evaluate the Efficacy and Safety of Oral Daily Rifamycin SV-MMX® 400 mg b.i.d. vs. Ciprofloxacin 500 mg
Brief Summary: The purpose of this study is to prove the non-inferiority of Rifamycin SV-MMX® versus Ciprofloxacin for the treatment of adults with traveller's diarrhoea.
Detailed Summary:
Sponsor: Dr. Falk Pharma GmbH
Current Primary Outcome: Time to Last Unformed Stool (TLUS) [ Time Frame: 24 hours ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Clinical cure [ Time Frame: 24 hours ]
Original Secondary Outcome: Same as current
Information By: Dr. Falk Pharma GmbH
Dates:
Date Received: September 23, 2010
Date Started: October 2010
Date Completion: March 2017
Last Updated: February 6, 2017
Last Verified: February 2017